AbSTRACT: In sheep, embryonic and fetal death during pregnancy can account for 25% to 50% of the total number of corpora lutea (and thus potential embryos). The objective of this study was to determine the effects of injectable and oral Arg supplementation provided for 14 d postbreeding on the reproductive performance of naturally stimulated fall lambing ewes. Rambouillet ewes (n = 210) were exposed to rams equipped with marking harnesses to induce cyclicity in April 2012. Upon estrus detection (d 0) ewes were randomly assigned, in a completely random design, to 1 of 6 treatments for a 14-d treatment period: injectable saline (CON; n = 25), injectable Ala (IVALA; n = 20), injectable Arg (IVARG; n = 23), oral rumen-protected Arg (RPARG; n = 20), oral fish meal (FM; n = 24), or oral soybean meal (SBM; n = 23). Daily treatments, except CON, IVALA, and SBM, were formulated to provide supplemental Arg at 30 mg·kg BW −1 ·d −1 and were provided at 0800 h daily. Ewes receiving injectable treatments were provided 454 g corn/d postinjection, whereas ewes receiving oral supplements were provided a ground ration of their respective treatments with corn individually at 0800 h daily. Plasma and serum samples were collected on d 0, 2, 4, 6, 8, 10, 12, and 14 from 12 ewes per treatment to evaluate plasma progesterone and serum AA concentrations. At lambing, birth weight, birth type, and sex were recorded. Weaning weights were recorded when the average age of lambs was 85 d. No differences (P ≥ 0.39) were detected for pregnancy, prolificacy, and lambing rates or lamb birth weights among treatments. However, litter weaning weight tended to be greater (P = 0.06) and weaning rates were greater (P = 0.05) in Arg-injected ewes (1.09, 0.95, 1.29, 0.72, 1.00, and 0.86, respectively). Plasma progesterone and serum Arg concentrations showed a treatment and day effect (P < 0.001), but no treatment × day interaction (P ≥ 0.99) was observed. In contrast to previous research, supplemental Arg during the first 14 d of pregnancy did not improve pregnancy or lambing rates; however, IVARG did positively impact weaning rates.
INTRODuCTION
The majority of embryonic losses in sheep occur before d 18 of gestation (Hulet et al., 1956; Moore et al., 1960; Quinlivan, 1966) . Loss of individual embryos can occur without complete loss of pregnancy, such as in the case of multiple fetuses (Rhind et al., 1980; Schrick and Inskeep, 1993) . In sheep, it has been reported that 30% of fertilized ova are not represented by live births, resulting in frequent, but unrecognized, loss (Bolet, 1986; Knights et al., 2003; Dixon et al., 2007) .
Research from our laboratories has indicated that periconceptual supplementation of the AA Arg can reduce these losses of embryos (Luther et al., 2009; Saevre et al., 2011b) . Treatment of ewes with injectable Arg during the time around maternal recognition of pregnancy improved pregnancy rate by 24% (Saevre et al., 2011b) and, when given for 15 d postbreeding, increased lambing rate by 50% (Luther et al., 2009) . Treatment with Arg in late pregnancy increases transport of nutrients to the unborn lamb through the synthesis of polyamines and NO, as observed by Thureen et al. (2002) , along with increased fetal protein accretion and increases in lamb birth weight (De Boo et al., 2005) . Additionally, AA such as Cit and Orn are essential to NO and polyamine synthesis. Quantifying serum concentrations of multiple AA may help explain reproductive responses, but most current research in sheep has not quantified these effects.
Previous research utilized an injectable Arg source, but for these results to become commercially applicable, an oral form of supplemental Arg must be developed. Our hypothesis was that injectable and supplemental Arg would increase pregnancy and lambing rates while decreasing postnatal lamb loss. The objective of this study was to compare the effects of injectable and oral Arg supplementation provided for 14 d postbreeding on the reproductive performance of naturally estrus stimulated fall lambing ewes.
MATERIALS AND METHODS
All procedures were approved by the Animal Care and Use Committee of North Dakota State University (NDSu; protocol A12038). This study was conducted at the NDSU Hettinger Research Extension Center in Hettinger, ND.
Experimental Design
Multiparous Rambouillet ewes (n = 210) aged 3 to 6 yr with a mean BW of 65 ± 6.8 kg grazed a mixed native prairie pasture encroached with crested wheatgrass (Agropyron cristatum) and smooth brome (Bromus inermis) and were supplemented with 454 g/d of whole corn. Ewes were then exposed to 15 ram lambs (approximately 10 mo of age) for 12 d to induce estrus in April of 2012. Three ewes that were marked by the ram lambs before study initiation were removed from the trial. After the 12-d exposure, the ram lambs were removed and mature Rambouillet rams (n = 10) equipped with marking harnesses were introduced to the ewe flock. Ewes were monitored daily at 0800 h to determine onset of estrus as indicated by breeding marks from the harnessed mature rams. Once estrus was detected, treatments were applied. The study used 6 treatments in a completely random design: control (CON; n = 25), intravenous (i.v.) Ala (IVALA; n = 20; Ajinomoto North America Inc., Raleigh, NC), i.v. Arg (IVARG; n = 23; Ajinomoto North America Inc.), rumen-protected Arg (RPARG; n = 20; Kemin Industries, Des Moines, IA), fish meal (FM; n = 24), and soybean meal (SbM; n = 23), and ewes received treatments (feed and injectable) indoors at an ambient temperature of 22.2°C ± 6°C.
Ewes assigned to IVARG, IVALA, or CON were administered i.v. injections of either Arg (30 mg·kg BW −1 ·d −1 of l-Arg), Ala (30 mg·kg BW −1 ·d −1 of l-Ala), or saline daily, respectively. All ewes were injected with the same treatment volumes (0.100 mL·kg BW −1 ·d −1 ) of saline or their respective AA solution. All ewes receiving injectable treatments were individually supplemented 454 g of corn daily. Similar to the studies of Luther et al. (2009) and Saevre et al. (2011b) , the IVARG and IVALA treatments were designed to provide 30 mg·kg BW −1 ·d −1 of metabolically available Arg and Ala, respectively. Oral supplementation treatments included RPARG (0.15 g/kg BW of rumen protected product [see below] mixed with ground corn), SBM (37.5:62.5 soybean meal:corn), and FM (25:75 fish meal:corn). All ewes were individually supplemented 454 g/d of their respective treatments. The RPARG and FM treatments were designed to provide 30 mg·kg BW −1 ·d −1 of metabolically available Arg, whereas SBM was designed to be isonitrogenous to FM. The amount of metabolically available Arg received in the treatments is based on prior Arg research (Luther et al., 2009; Saevre et al., 2011a,b) and is based on calculations of bypass protein and typical Arg concentrations in feed types (NRC, 2007) .
Animal Management
During the entire treatment period, all ewes were group fed a basal ration outdoors daily that consisted of 1.88 kg alfalfa hay, 0.226 kg barley haylage, and 0.023 kg trace mineral (DM basis; Table 1 ). Ewes were provided water ad libitum.
The nutrient composition of the dietary ingredients is described in Table 1 , including Arg%, rumen undegradable Arg (RuArg = Arg% × RUP), microbial Arg Feed samples from the basal ration were taken once every 2 d as bunks were filled. Samples of treatment feeds were taken each time a new ration was mixed. (method 973.18; AOAC Int., 1990) .
Arginine was provided through both the basal ration and the treatment received (mg·kg BW −1 ·d −1 ; Table 2 ). Control and IVALA treatments received 203 mg·kg BW −1 ·d −1 MetArg, whereas IVARG ewes received 233 mg·kg BW −1 ·d −1 of MetArg. Rumen-protected Arg and SBM-treated ewes received a total of 250 mg·kg All ewes were housed in pens of 15 and bunk fed ad libitum a total mixed ration consisting of 14.6% ground hay, 37% barley grain, 47% barley haylage, and 1.4% of a trace mineral supplement (DM basis; Table 3 ). Ewes were observed for parturition every 2 h beginning on d 130 and moved with lambs (within 2 h of birth) to a separate lambing pen (0.9 × 1.5 m lambing pen), where ewes and lambs were allowed time to bond. Within 2 h of birth, birth BW, birth type (single, twin, triplet), and sex of lamb were recorded. Once lambs were bonded to their dam (attentive and nursing), ewes and lambs were removed from the small lambing pens and moved into a larger (7.6 m × 3.7 m) grouping pen where lambs were provided a grower pellet via a creep feeder ad libitum until weaning, which included 38% CP, 1% crude fat, 4%-5% Ca, 0.6% P, 3.5%-4.5% salt, 3.0 mg/kg Se, 52,800 IU/kg vitamin A, 5,280 IU/kg vitamin D, and 132 IU/kg vitamin E (DM basis). The grower pellet was also medicated with chlortetracycline at a rate of 4.4 g/kg of feed. Individual lamb BW were recorded at the time of weaning when the average lamb age was 85 ± 15 d.
Blood Sampling
Blood samples were collected via jugular venipuncture (20 gauge × 2.54 cm needle; BD Short Bevel Needles, 305178, Becton, Dickinson and Co., Franklin Lakes, NJ) into 10 mL serum (BD Vacutainer Serum, 367820, Becton, Dickinson and Co.) and 10 mL plasma tubes (BD Vacutainer Plasma-Heparin coated, 36648, Becton, Dickinson and Co.) on d 0, 2, 4, 6, 8, 10, 12, and 14 from the same 12 randomly selected ewes per treatment before the treatment was administered at 0800 h and immediately placed on ice. Plasma samples were then centrifuged at 4°C for 30 min at 1,500 × g, and both serum and plasma were transferred into plastic 2.0-mL microcentrifuge tubes and frozen at −20°C until assayed 60 d postcollection. Plasma samples were assayed for concentrations of circulating progesterone using IMMULITE 1000 (Siemens Healthcare Diagnostics, Erlangen, Germany; Galbreath et al., 2008) . Five ewes were randomly selected from each treatment group, and their serum samples were assayed for AA concentrations using fluorometric HPLC, similar to what was done in Lekatz et al. (2011) .
Statistical Analyses
Pregnancy, prolificacy, lambing rates, and weaning rates were analyzed using the GLIMMIX procedure of SAS (SAS Inst. Inc., Cary, NC) in this completely random design. Pregnancy rates were defined as the percentage of pregnant ewes per ewe treated. Prolificacy was considered the number of lambs born per ewe lambed, whereas lambing rate was the number of lambs born per ewe receiving a treatment. Weaning rate was defined as the number of lambs weaned per ewe that lambed. Birth BW, litter weaning BW, serum amino acid, and plasma progesterone concentrations were analyzed using the MIXED procedure of SAS. When analyzing pregnancy, lambing rates, birth BW, and adjusted litter BW, the model included either birth type or weaning rate. The model included fixed effects of dietary treatment, day, and treatment × day and the random effect of ewe. Significance was determined at P ≤ 0.05, and trends were discussed when P < 0.10. To partition treatment and day effects and treatment × day interactions, LSMEANS and PDIFF were utilized (P ≤ 0.05).
RESuLTS
No differences (P ≥ 0.39; Table 4) were detected for pregnancy percentage, prolificacy, or lambing rates among treatments. However, weaning rate was greatest for IVARG-treated ewes (P = 0.05) and least for RPARG ewes (P = 0.05), with the other treatments being intermediate. There were also no differences (P ≥ 0.21) for lamb birth or adjusted litter weaning (Table 5) ; however, when litter weaning BW were analyzed, there was a tendency (P = 0.06) for lambs born to IVARG ewes to weigh more than lambs born to RPARG ewes, whereas lambs born to RPARG ewes had the smallest litter weaning BW. There was no treatment × day interaction detected for plasma progesterone concentrations (P ≥ 0.99); however, there were treatment (P < 0.001) and day (P < 0.001) effects, with progesterone concentrations increasing linearly from d 0 through d 14 (0.33 ± 0.43, 0.60 ± 0.42, 1.52 ± 0.42, 2.70 ± 0.42, 3.46 ± 0.42, 3.55 ± 0.42, 3.99 ± 0.42, and 4.07 ± 0.42 ng/mL, respectively). The CON, IVALA, and RPARG ewes had similar (P < 0.001) levels of progesterone (2.79 ± 0.42, 2.74 ± 0.42, and 2.74 ± 0.43 ng/mL, respectively), which were greater than those of the ewes receiving IVARG, FM, and SBM treatments (Table 4 ). The RPARG-treated ewes had greater (P < 0.001) progesterone concentrations than the FM, SBM, and IVARG ewes.
No treatment × day interaction (P = 0.99) was observed for serum Arg concentrations; however, there were treatment and day effects (P < 0.001 and P < 0.001, respectively; Table 6 ). Serum Arg concentrations increased linearly from d 0 through d 14 (P ≤ 0.05; data not shown; 161.8 ± 24.9, 171.7 ± 24.9, 173.8 ± 24.9, 181.9 ± 24.9, 193.5 ± 24.9, 191.8 ± 24.9, 195.2 ± 24.9, 205 .1 ± 24.9 μmol/L). The treatment exhibiting the greatest (P < 0.001) serum Arg concentration was SBM, with FM exhibiting the lowest concentration; all other treatments were intermediate for serum Arg (Table 6) . Serum concentrations for Ala showed no treatment × day interaction (P = 0.78), although a treatment effect was exhibited, as well as a day effect (P < 0.001 and P = 0.003, respectively; Table 6 ). For serum Ala, RPARG was lower (P ≤ 0.04) than CON or IVARG, with all other treatments being intermediate (Table 6 ). The day effect (P = 0.003) exhibited for Ala had similar (P = 0.06) concentrations at d 0 and 2 and then exhibited increased (P < 0.007) concentrations for d 4 through 14, although all of the days were similar (P ≥ 0.07) to one another, with the exception of d 0 (P < 0.001). There was no treatment × day interaction (P = 0.29) or day effect (P = 0.99; Table 6 ) for serum concentration of β-Ala. Additionally, there were differences (P = 0.013) in concentration of serum β-Ala observed between treatments, with the sole difference being RPARG, which was lower (P ≤ 0.04) than all treatments except CON (P = 0.14; Table 6 ). Serum concentrations of Cit were greatest (P < 0.001) for the IVALA treatment, least for FM, and intermediate for all other treatments (P ≥ 0.16; 233.72 ± 7.8, 214.70 ± 7.8, and 204.97 ± 7.8 μmol/L, respectively; Table 6 ); however, there was no day effect for Cit (P = 0.96; Table 6 ). Ornithine exhibited no treatment × day interaction (P = 0.98). Ornithine serum concentrations with respect to treatment were least (P < 0.001) for IVARG-treated ewes, greatest for RPARG, FM, and SBM, and intermediate in CON-and IVALAtreated ewes (52.13 ± 18.2 and 47.50 ± 18.2 μmol/L, respectively) but exhibited no day effect (P = 0.94).
Two treatment × day interactions were observed for the remaining serum AA concentrations measured: hydroxylysine-2 (Hyl2; P < 0.001; Table 6 ) and γ-amino-N-butyric acid (GAbA; P < 0.001; Table 6), with concentrations tending to decrease over time for Hyl2 (no values for d 0 and 4 as the concentrations on those days were below the limit of detection for the assay), whereas GABA tended to increase over time. Hydroxylysine-2 concentrations were increased (P < 0.001) in FM-treated ewes compared to ewes receiving all other treatments. Concentrations of GABA were increased (P < 0.001) for ewes receiving FM (9.88 ± 0.4 μmol/L) and also exhibited a day effect (P = 0.04), with concentrations tending to increase over the 14-d period. There were no other treatment × day interactions detected (P ≥ 0.77) for serum AA 1 Pregnancy = percentage pregnant per ewe treated; prolificacy = lambs per ewe lambed; lambing rate = lambs per ewe treated; weaning rate = lambs weaned per ewe lambing. concentrations. The complete serum AA concentration profile is presented in Table 7 ; however, not all of the AA are discussed. Only the AA concentrations thought to offer possible insight to the existing trial were included in the results and discussion (Table 6 ).
DISCuSSION
Pregnancy rates were not influenced through injectable or oral treatments in our study. Similarly, Luther et al. (2009) observed no differences in pregnancy rates for supplementation with injectable Arg from d 0 through 14. In contrast, pregnancy rates were greater in ewes supplemented with injectable Arg from d 9 through 14 postbreeding (Saevre et al., 2011b) . In the aforementioned studies (Luther et al., 2009; Saevre et al., 2011b) , pregnancy rates ranged from 45% to 55%, whereas pregnancy rates were approximately 88% for the current study. The differences in pregnancy rates between these studies could be due to a difference in estrus synchronization techniques utilized. Ewes in the previous 2 studies were synchronized artificially with a controlled internal drug release insert and an injection of PG600 (containing 400 IU of eCG and 200 IU of hCG), whereas the ewes in the current study were naturally synchronized using ram exposure.
In the present study, only 1.5% of ewes displayed estrus prior to the beginning of the trial, indicating most of the flock was in a period of anestrus before ram introduction. Gonzalez-Bulnes et al. (2005) provided evidence that progestogens, when compared with prostaglandin-type products, might have negative effects on the ovulatory follicles. These follicles showed deficiencies in estradiol secretion during the preovulatory phase, which could prevent the oocyte from developing into a viable embryo (Gonzalez-Bulnes et al., 2005) . Leoni et al. (2001) reported ewes given superovulatory treatment with eCG/FSH had increased ovarian responses compared to FSH alone; however, the embryos showed a reduced viability rate. In hamsters, embryos harvested from PMSG-treated females and implanted into recipients showed a 2-fold decrease in viability posttransfer compared to nonstimulated hamsters (McKiernan and Bavister, 1998) . Although the aforementioned studies were all performed using embryo transfer, results show artificial use of exogenous hormones can severely affect the viability of the ovulating follicles and, subsequently, the embryos, suggesting Arg may be more useful in systems using these artificial methods.
Prolificacy was not influenced through injectable or oral treatments in the present study. Similarly, Saevre et al. (2011b) reported no influence on prolificacy using injectable l-Arg. However, Luther et al. (2009) demonstrated differences in prolificacy, with 1.6 lambs born per ewe treated with injectable Arg vs. 1.1 for control ewes. In the present study, we observed an average of 1.1 lambs born per ewe. Ovulation rates in out-ofseason ewes have been shown to decrease by at least 15% compared with in-season ewes (Glimp, 1971) . Lunstra and Christenson (1981) demonstrated that with administration of progesterone and PMSG, ovulation rates of out-of-season ewes could be increased by 50%. Because of these varying results, more research is needed on the use of exogenous hormones in anestrous ewes and the effects on lambing rates on in-season and out-of-season ewes. It is possible that with hormonal induction of estrus, ewes might have increased ovulation rates. However, as mentioned above, the oocytes would potentially be less viable. Ewes naturally induced to exhibit estrus, whether through manipulation of ambient light or ram introduction, have lower rates of ovulation, but the oocytes may be healthier with increased viability. With limited research comparing embryo quality in naturally stimulated ewes to those artificially stimulated, it is difficult to make a definitive conclusion regarding this hypothesis. Arginine supplementation could be recovering these less viable embryos when in compromised situations but might have no effect when ovarian function is stimulated via noncompromised models without exogenous hormone use, such as the ram effect.
No differences in adjusted litter weaning BW were observed, and we are unaware of any prior research with exogenous Arg that has reported weaning data in sheep. However, there was a tendency, when number of lambs born was not considered, for litter weaning weights of IVARG-treated lambs to be increased but for litter weaning rates of RPARG-treated ewes to be reduced when compared to other treatments. This is likely due to singles generally having increased performance compared to lambs of multiple births since the tendency is nonexistent when number of lambs born is included in the model. However, with the previous conclusion that Arg supplementation might possibly be recovering less viable embryos, it is possible that these lambs were born less thrifty, resulting in lower litter weaning weights. However, this is perplexing and quite speculative since IVARG-treated ewes tended to have the greatest litter weaning weights, and RPARG lamb weights were still lowest. Potentially, the RPARG treatment could be providing too much Arg and upregulating NO (or perhaps polyamine) synthesis to pathological or even toxic levels, thereby compromising the health and performance of the preweaning lambs (Buhimschi et al., 1998) . More research needs to be performed to address why the lambs from the RPARG ewes underperformed prior to weaning. However, another possibility is the RPARG carrier used for this product.
In the current trial, plasma progesterone levels increased linearly throughout the first 14 d of pregnancy, as would be expected. However, RPARG had the highest progesterone levels of the treatments, being similar to the CON and IVALA treatments. This is worth noting since RPARG had the numerically lowest prolificacy, whereas the CON ewes were among the most prolific and the IVALA ewes fell in the numerical median for prolificacy. This may eliminate prolificacy as the driving factor of increased progesterone levels, unless there was a significant embryonic loss after d 14 of pregnancy when progesterone ceased to be measured. Our results are not able to determine if this in fact happened Serum levels of Arg were elevated only in ewes receiving SBM, with both of the supplemental Arg treatments exhibiting serum Arg levels similar to those of the CON ewes. Only 1 oral supplement treatment (SBM) succeeded in elevating serum Arg levels, although it was high protein, not a known source of feed-grade Arg. Saevre et al. (2011b) observed an increased level of serum Arg concentrations in ewes that received i.v. Arg when compared to control ewes; Saevre et al. (2011a) also reported that rumen-protected Arg provided at much greater levels in the diet (360 mg/kg BW) did increase serum Arg levels on d 11 and 12 of pregnancy compared to levels in ewes on the control diet or ewes receiving dietary levels of Arg at 90 mg Arg/kg BW or 180 mg Arg/kg BW. It is also important to note that Ala concentrations were elevated in the i.v. Ala ewes, as well as in control ewes.
Citrulline concentrations were increased in IVALA and, to a lesser extent, in IVARG-treated ewes. In contrast, Saevre et al. (2011a,b) reported no effects on Cit levels, which could be due to timing of serum samples being taken since Cit is utilized for production of Arg and its half-life in circulation is short (Wu and Morris, 1998) . It could also be due to an increased need for Arg synthesis and therefore an increase in production of Cit; however, this does not agree with results from our current trial. Therefore, further research is needed to elucidate possible factors affecting Cit concentrations.
Ornithine concentrations were lowest in IVARG ewes, which is interesting because increased Cit levels were observed in IVARG ewes and Orn is a precursor to Cit in the synthesis of Arg. However, this could again be due to timing of blood sampling, or possibly, the ammonia to carbamoyl phosphate pathway was 1 Hyl2 = hydroxylysine 2; GABA = gamma-amino-N-butyric acid. utilized to synthesize Cit via carbamoyl-phosphate synthase I vs. the Orn pathway (Wu and Morris, 1998) . Treatments exhibiting increased Orn concentrations in serum were RPARG, FM, and SBM, which could be the result of a difference in the protein supplied by the different feedstuffs.
Concentrations of GABA were elevated in ewes receiving FM, which could have impacts on polyamine synthesis (McCann et al., 1979) . McCann et al. (1979) reported GABA, when added to rat hepatoma cells at the time of induction of cell proliferation, increased levels of ornithine decarboxylase, the rate-limiting enzyme in polyamine synthesis, by 2-to 3-fold when compared to control cells. The increase in ornithine decarboxylase was also reflected by increases in intracellular putrescine levels, whereas spermidine and spermine were unchanged. McCann et al. (1979) reported GABA's stabilizing effect on ornithine decarboxylase could be important in certain types of cells for the regulation of polyamine biosynthesis, which is important for placental development (Wu and Morris, 1998) .
As expected, Hyl2 concentrations also were greatest in ewes receiving FM, and FM is an excellent source of Hyl2 (Folador et al., 2006) . Although data for this AA were not commonly reported, it is a component of type III collagen and is used for structural elements in blood vessels. Therefore, increased levels of Hyl2 could contribute to vascular growth in gravid uterine tissues of FM-supplemented ewes. Arginine is important for many biological functions, including synthesis of NO and polyamines (Gouge et al., 1998; Manser et al., 2004; Wu et al., 2013) . It has been hypothesized that treating ewes with Arg at, or slightly before, the time of maternal recognition of pregnancy may enhance survival of the embryo during early embryogenesis (Luther et al., 2009) . This is likely accomplished through the role Arg plays in polyamine and NO synthesis. Gestating sows supplemented with dietary Arg achieved a 22% increase in live piglets born (11.4 vs. 9.4 live piglets, respectively; P < 0.03; Mateo et al., 2007) . Furthermore, pregnant rats provided injectable 1.3% Arg HCl throughout pregnancy or between d 1 and 7 of gestation had increased embryonic survival, and litter size increased by 30% (Zeng et al., 2008) .
The most important factor affecting the success of most commercial sheep operations is reproductive efficiency (Lupton, 1998) . New advancements in technology offer the possibility for significant improvements in the efficiency of lamb production. With a volatile market continuing to potentially decrease profit margins, an increased emphasis, by producers and scientists alike, has been placed on maximizing lamb profitability. For Arg supplementation to become more commercially applicable, an oral form of supplemental Arg should be developed. However, the studies thus far with oral supplementation have used models of compromised maternal statuses (Lassala et al., 2010; Saevre et al., 2011a,b; Peine et al., 2014) , and results have been those of the control ewes. In the current study, utilizing ewes synchronized for estrous through ram exposure for fall lambing, we reject the hypothesis that supplemental Arg will increase pregnancy rates and lambing rates; however, injectable Arg did increase litter weaning weights and also improved weaning rates.
Although some previous research suggests embryonic survival in sheep can be enhanced when ewes are supplemented with Arg, we did not detect any improvements in reproductive performance or lamb growth in ewes supplemented with different forms of Arg. Rumen-protected Arg should be further investigated to determine why litter weaning weights and rates were decreased. We also believe that further research is warranted to examine the rate of reproductive loss with different methods of out-of-season estrus induction and the ability of supplemental Arg to overcome these losses. 
